190 related articles for article (PubMed ID: 22453590)
21. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
Squire RA; Goode K
J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
[TBL] [Abstract][Full Text] [Related]
22. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
[TBL] [Abstract][Full Text] [Related]
23. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
Abeck D;
Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
[TBL] [Abstract][Full Text] [Related]
24. Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study.
Shemer A; Kaplan B; Nathansohn N; Grunwald MH; Amichai B; Trau H
Isr Med Assoc J; 2008 Jun; 10(6):417-8. PubMed ID: 18669136
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
[TBL] [Abstract][Full Text] [Related]
26. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
[TBL] [Abstract][Full Text] [Related]
27. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
Ozden MG; Tekin NS; Ilter N; Ankarali H
Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.
Altmeyer P; Hoffmann K;
Int J Dermatol; 2004 Jul; 43 Suppl 1():9-12. PubMed ID: 15271194
[TBL] [Abstract][Full Text] [Related]
29. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
[TBL] [Abstract][Full Text] [Related]
30. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
[TBL] [Abstract][Full Text] [Related]
31. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
Seckin D; Gurbuz O; Akin O
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
[TBL] [Abstract][Full Text] [Related]
33. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
Shuster S; Meynadier J; Kerl H; Nolting S
Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
[TBL] [Abstract][Full Text] [Related]
34. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study.
Ortonne JP; Nikkels AF; Reich K; Ponce Olivera RM; Lee JH; Kerrouche N; Sidou F; Faergemann J
Br J Dermatol; 2011 Jul; 165(1):171-6. PubMed ID: 21707573
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial.
Scaparro E; Quadri G; Virno G; Orifici C; Milani M
Br J Dermatol; 2001 Apr; 144(4):854-7. PubMed ID: 11298548
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of 1% ciclopirox shampoo in the treatment of moderate-to-severe scalp seborrheic dermatitis: a multicenter, prospective, assessor-blinded trial.
Veraldi S; Barbareschi M; Martella A; Milani M
G Ital Dermatol Venereol; 2019 Jun; 154(3):342-346. PubMed ID: 31001967
[TBL] [Abstract][Full Text] [Related]
37. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent.
Piérard GE; Ausma J; Henry F; Vroome V; Wouters L; Borgers M; Cauwenbergh G; Piérard-Franchimont C
Dermatology; 2007; 214(2):162-9. PubMed ID: 17341867
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
Gold M; Dhawan S; Verma A; Kuligowski M; Dobrowski D
J Drugs Dermatol; 2016 Jun; 15(6):743-8. PubMed ID: 27272083
[TBL] [Abstract][Full Text] [Related]
39. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
